tradingkey.logo
tradingkey.logo
Search

Gyre Therapeutics Inc

GYRE
Add to Watchlist
5.650USD
-0.340-5.68%
Close 07-29 16:00ETQuotes delayed by 15 min
516.05MMarket Cap
LossP/E TTM

GYRE Financials

See Gyre Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Gyre Therapeutics Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.10/-0.07
Revenue / Forecast
22.52M/31.61M
Period
FY2025 Earnings
Revenue(YoY)
116.59M
10.24%
EPS(YoY)
0.06
-60.38%
Analyst Rating
BUY
2026/07/29
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-404.84%-0.10
-1541.74%-0.02
202.90%0.04
-87.98%0.00
-65.49%0.03
99.67%0.00
-79.02%0.01
104.21%0.04
-12.47%0.09
98.18%-0.35
--0.06
---0.98
--0.10
---19.10
----
----
----
----
----
----
Revenue
2.09%22.52M
33.45%37.20M
19.92%30.56M
6.13%26.77M
-18.82%22.06M
-75.43%27.87M
-20.45%25.49M
--25.23M
--27.17M
--113.45M
--32.04M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-45.88%794.00K
20.14%2.44M
157.45%2.30M
-31.72%1.13M
Net Profit
-422.13%-8.69M
-1640.40%-1.72M
221.17%3.61M
-87.47%442.00K
-64.18%2.70M
99.89%-99.00K
-71.73%1.12M
242.72%3.53M
2796.92%7.53M
-120.36%-89.14M
181.41%3.98M
-104.79%-2.47M
101.79%260.00K
-99.00%-40.45M
80.65%-4.88M
359.09%51.63M
35.22%-14.54M
-7.52%-20.33M
-57.41%-25.24M
-15.54%-19.93M
Net Margin
-358.60%-43.78%
-279.90%-3.67%
73.33%19.42%
-67.28%5.89%
-53.70%16.93%
102.84%2.04%
-52.19%11.21%
--17.99%
--36.56%
---72.01%
--23.44%
----
----
----
----
----
----
----
----
----
Gross Margin
-1.45%94.55%
-0.48%95.31%
-1.63%94.67%
-1.29%95.70%
-0.47%95.95%
-0.14%95.78%
-0.07%96.24%
--96.95%
--96.40%
--95.91%
--96.30%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
----
----
----
----
----
----
Revenue
2.09%22.52M
33.45%37.20M
19.92%30.56M
6.13%26.77M
-18.82%22.06M
-75.43%27.87M
-20.45%25.49M
--25.23M
--27.17M
--113.45M
--32.04M
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-45.88%794.00K
20.14%2.44M
157.45%2.30M
-31.72%1.13M
Operating profit
-399.25%-6.80M
-81.90%120.00K
63.60%6.92M
-33.45%2.17M
-71.84%2.27M
-97.63%663.00K
-66.84%4.23M
228.27%3.26M
277.07%8.07M
679.01%27.94M
347.08%12.76M
55.50%-2.54M
66.73%-4.56M
76.25%-4.83M
79.52%-5.17M
71.30%-5.71M
38.94%-13.70M
-7.81%-20.31M
-56.70%-25.23M
-14.71%-19.91M
Net Profit
-422.13%-8.69M
-1640.40%-1.72M
221.17%3.61M
-87.47%442.00K
-64.18%2.70M
99.89%-99.00K
-71.73%1.12M
242.72%3.53M
2796.92%7.53M
-120.36%-89.14M
181.41%3.98M
-104.79%-2.47M
101.79%260.00K
-99.00%-40.45M
80.65%-4.88M
359.09%51.63M
35.22%-14.54M
-7.52%-20.33M
-57.41%-25.24M
-15.54%-19.93M
Current assets
34.02%91.73M
58.01%102.37M
79.85%98.58M
70.57%91.28M
9.13%68.45M
13.22%64.79M
967.99%54.81M
602.35%53.52M
347.57%62.72M
102.87%57.22M
-83.03%5.13M
-90.63%7.62M
-61.82%14.01M
-45.21%28.21M
-59.11%30.25M
-16.03%81.31M
-68.50%36.70M
-42.49%51.48M
-31.50%73.96M
-20.21%96.83M
Total current liabilities
4.20%19.79M
-6.30%18.29M
8.13%15.91M
8.64%16.92M
-2.54%18.99M
-2.65%19.52M
725.35%14.72M
457.61%15.57M
184.72%19.49M
19.16%20.05M
8.45%1.78M
-35.21%2.79M
-48.11%6.84M
18.77%16.82M
-90.47%1.64M
-72.31%4.31M
-6.99%13.19M
-20.40%14.16M
2.56%17.25M
13.93%15.57M
Total assets
24.83%162.01M
32.48%166.13M
27.26%159.38M
26.23%152.65M
6.38%129.79M
7.61%125.41M
1156.92%125.24M
875.71%120.93M
550.72%122.01M
309.71%116.54M
-67.88%9.96M
-85.13%12.39M
-53.44%18.75M
-48.90%28.44M
-60.50%31.02M
-18.09%83.37M
-66.18%40.27M
-41.31%55.66M
-29.75%78.54M
-17.70%101.79M
Total liabilities
-1.80%25.03M
-11.68%23.85M
-17.92%21.97M
-15.88%23.20M
-23.32%25.49M
-29.06%27.00M
315.17%26.77M
272.79%27.58M
385.67%33.24M
126.25%38.06M
292.15%6.45M
71.63%7.40M
-48.11%6.84M
15.45%16.82M
-90.76%1.64M
-74.06%4.31M
-11.99%13.19M
-22.39%14.57M
0.32%17.80M
12.90%16.62M
Total equity
31.33%136.99M
44.59%142.28M
39.54%137.41M
38.67%129.44M
17.50%104.30M
25.39%98.40M
2699.94%98.47M
1768.79%93.35M
1106.78%88.77M
575.34%78.47M
-88.03%3.52M
-93.68%5.00M
-72.84%7.36M
-71.72%11.62M
-51.63%29.38M
-7.16%79.06M
-73.98%27.08M
-45.98%41.09M
-35.43%60.74M
-21.84%85.16M
Net operating income
2565.12%3.18M
-103.95%-5.63M
170.92%4.68M
138.01%2.09M
-104.47%-129.00K
-107.30%-2.76M
153.65%1.73M
-122.30%-5.49M
146.40%2.88M
2662.44%37.80M
55.79%-3.22M
79.90%-2.47M
48.41%-6.22M
91.66%-1.48M
66.31%-7.28M
38.91%-12.29M
50.53%-12.05M
20.07%-17.68M
-66.05%-21.60M
-32.95%-20.12M
Net investment
-255.31%-3.06M
192.22%1.85M
47.76%-1.25M
63.23%-3.04M
127.24%1.97M
91.97%-2.00M
---2.39M
-272.53%-8.27M
-1856.69%-7.22M
-49052.94%-24.97M
--0.00
-90.93%4.79M
-83.59%411.00K
-98.22%51.00K
-100.00%0.00
393.94%52.87M
-90.92%2.50M
-89.60%2.87M
133.09%7.04M
144.52%10.70M
Net financing
-98.44%21.00K
-67.01%318.00K
12.65%365.00K
14227.56%22.35M
104.26%1.34M
-93.67%964.00K
121.92%324.00K
104.46%156.00K
108.48%658.00K
--15.24M
96.72%-1.48M
---3.50M
-48612.50%-7.76M
--0.00
-46045.92%-45.03M
100.00%0.00
-99.97%16.00K
--0.00
230.67%98.00K
-100.01%-4.00K

FAQs

What is the total revenue of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its total revenue reached 116.59M, with a year-on-year change of 105.76M.

What are the current assets of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its current assets were 102.37M, with a year-on-year change of 58.01.

What are the total assets of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its total assets of Gyre Therapeutics Inc were 166.13M, with a year-on-year change of 32.48.

What are the total liabilities of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its total liabilities of Gyre Therapeutics Inc were 23.85M, with a year-on-year change of -11.68.

What is the total equity of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its total equity of Gyre Therapeutics Inc was 142.28M, with a year-on-year change of 44.59.

What is the net operating income of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its net operating income of Gyre Therapeutics Inc was 11.49M, with a year-on-year change of -29.19.

What is the net investment of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its net investment of Gyre Therapeutics Inc was -474.00K, with a year-on-year change of 97.62.

What is the net financing of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its net financing of Gyre Therapeutics Inc was 24.38M, with a year-on-year change of 1059.75.

What is the Earnings Per Share (EPS) of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.06, with a year-on-year change of -60.38.

What is the net income of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its net income was 5.03M, with a year-on-year change of -58.40.

What is the net margin of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its net profit margin was 8.47, with a year-on-year change of -49.93.

What is the gross margin of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its gross margin was 95.35, with a year-on-year change of -1.01.

What is the Return on Equity (ROE) of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 5.94, with a year-on-year change of -88.33.

What is the Return on Assets (ROA) of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 6.78, with a year-on-year change of -54.19.

What is the operating profit of Gyre Therapeutics Inc?

According to Gyre Therapeutics Inc's FY2025 earnings report, its operating profit was 11.49M, with a year-on-year change of -29.19.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.